CV Sciences, Inc. 8-K

What Happened

• CV Sciences, Inc. filed an 8-K reporting results of its virtual 2026 Annual Meeting held June 2, 2026 (record date April 6, 2026). There were 193,458,420 shares outstanding and 116,234,784 shares (≈60.1%) represented, establishing a quorum.
• Stockholders elected three directors to serve until the next annual meeting: Dr. Jamie Corroon, Joseph Dowling, and Bill McCorkle. Voting tallies were: Dr. Jamie Corroon — For 39,505,495; Against 3,183,772; Abstain 1,078,738; Broker Non-Vote 72,466,779. Joseph Dowling — For 37,674,977; Against 4,813,319; Abstain 1,279,709; Broker Non-Vote 72,466,779. Bill McCorkle — For 22,671,092; Against 3,928,542; Abstain 17,168,371; Broker Non-Vote 72,466,779.
• Proposal to authorize the Board to effect a reverse stock split (ratio between 1-for-10 and 1-for-800) was not approved: For 48,496,747; Against 59,628,926; Abstain 8,109,111.
• Stockholders ratified Haskell & White LLP as the company’s independent registered public accounting firm for fiscal year 2026: For 102,384,289; Against 12,488,529; Abstain 1,361,966.

Key Details

• Annual Meeting date: June 2, 2026 (virtual); record date: April 6, 2026.
• Outstanding shares on record date: 193,458,420; shares represented at meeting: 116,234,784 (~60.1%).
• Reverse stock split vote: rejected (48,496,747 for vs. 59,628,926 against).
• Auditor ratified: Haskell & White LLP (102,384,289 for).

Why It Matters

• Board continuity: Election of three directors confirms leadership for the coming year and affects governance and strategic oversight. Joseph Dowling, the CEO, was among those elected.
• Share structure: The rejection of the reverse stock split means the company will not consolidate shares under the proposed 1-for-10 to 1-for-800 range unless a future vote approves such an action. That preserves the current share count and market float for now.
• Financial reporting: Ratification of Haskell & White LLP provides continuity for the company’s external audit of 2026 financial statements.
• Voter turnout (~60.1%) shows a majority of outstanding shares participated by proxy, providing clear shareholder direction on these governance matters.